These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 13679369)
1. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. Hodder AN; Drew DR; Epa VC; Delorenzi M; Bourgon R; Miller SK; Moritz RL; Frecklington DF; Simpson RJ; Speed TP; Pike RN; Crabb BS J Biol Chem; 2003 Nov; 278(48):48169-77. PubMed ID: 13679369 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. McCoubrie JE; Miller SK; Sargeant T; Good RT; Hodder AN; Speed TP; de Koning-Ward TF; Crabb BS Infect Immun; 2007 Dec; 75(12):5565-74. PubMed ID: 17893128 [TBL] [Abstract][Full Text] [Related]
3. Structural insights into the protease-like antigen Plasmodium falciparum SERA5 and its noncanonical active-site serine. Hodder AN; Malby RL; Clarke OB; Fairlie WD; Colman PM; Crabb BS; Smith BJ J Mol Biol; 2009 Sep; 392(1):154-65. PubMed ID: 19591843 [TBL] [Abstract][Full Text] [Related]
4. Characteristic features of the SERA multigene family in the malaria parasite. Arisue N; Palacpac NMQ; Tougan T; Horii T Parasit Vectors; 2020 Apr; 13(1):170. PubMed ID: 32252804 [TBL] [Abstract][Full Text] [Related]
5. Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte. Ruecker A; Shea M; Hackett F; Suarez C; Hirst EM; Milutinovic K; Withers-Martinez C; Blackman MJ J Biol Chem; 2012 Nov; 287(45):37949-63. PubMed ID: 22984267 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5. Fairlie WD; Spurck TP; McCoubrie JE; Gilson PR; Miller SK; McFadden GI; Malby R; Crabb BS; Hodder AN Infect Immun; 2008 Sep; 76(9):4332-44. PubMed ID: 18591232 [TBL] [Abstract][Full Text] [Related]
7. Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2. Pandey KC; Sijwali PS; Singh A; Na BK; Rosenthal PJ J Biol Chem; 2004 Jan; 279(5):3484-91. PubMed ID: 14625277 [TBL] [Abstract][Full Text] [Related]
8. The Plasmodium falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of malaria parasite egress from host erythrocytes. Collins CR; Hackett F; Atid J; Tan MSY; Blackman MJ PLoS Pathog; 2017 Jul; 13(7):e1006453. PubMed ID: 28683142 [TBL] [Abstract][Full Text] [Related]
9. The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite. Putrianti ED; Schmidt-Christensen A; Arnold I; Heussler VT; Matuschewski K; Silvie O Cell Microbiol; 2010 Jun; 12(6):725-39. PubMed ID: 20039882 [TBL] [Abstract][Full Text] [Related]
10. Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5. Tanabe K; Arisue N; Palacpac NM; Yagi M; Tougan T; Honma H; Ferreira MU; Färnert A; Björkman A; Kaneko A; Nakamura M; Hirayama K; Mita T; Horii T Vaccine; 2012 Feb; 30(9):1583-93. PubMed ID: 22230587 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory potential of prodomain of Plasmodium falciparum protease serine repeat antigen 5 for asexual blood stages of parasite. Alam A; Chauhan VS PLoS One; 2012; 7(1):e30452. PubMed ID: 22291957 [TBL] [Abstract][Full Text] [Related]
12. Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria. Rahul CN; Shiva Krishna K; Pawar AP; Bai M; Kumar V; Phadke S; Rajesh V J Biomol Struct Dyn; 2014 Apr; 32(4):580-90. PubMed ID: 23582016 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle. Stallmach R; Kavishwar M; Withers-Martinez C; Hackett F; Collins CR; Howell SA; Yeoh S; Knuepfer E; Atid AJ; Holder AA; Blackman MJ Mol Microbiol; 2015 Apr; 96(2):368-87. PubMed ID: 25599609 [TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides derived from the C-terminal 6kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development. Kanodia S; Kumar G; Rizzi L; Pedretti A; Hodder AN; Romeo S; Malhotra P Biochim Biophys Acta; 2014 Sep; 1840(9):2765-75. PubMed ID: 24769454 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium. Hansen G; Heitmann A; Witt T; Li H; Jiang H; Shen X; Heussler VT; Rennenberg A; Hilgenfeld R Structure; 2011 Jul; 19(7):919-29. PubMed ID: 21742259 [TBL] [Abstract][Full Text] [Related]
16. Falcipains and other cysteine proteases of malaria parasites. Rosenthal PJ Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657 [TBL] [Abstract][Full Text] [Related]
17. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. Aoki S; Li J; Itagaki S; Okech BA; Egwang TG; Matsuoka H; Palacpac NM; Mitamura T; Horii T J Biol Chem; 2002 Dec; 277(49):47533-40. PubMed ID: 12244052 [TBL] [Abstract][Full Text] [Related]
18. A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. Miller SK; Good RT; Drew DR; Delorenzi M; Sanders PR; Hodder AN; Speed TP; Cowman AF; de Koning-Ward TF; Crabb BS J Biol Chem; 2002 Dec; 277(49):47524-32. PubMed ID: 12228245 [TBL] [Abstract][Full Text] [Related]
19. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites. Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342 [TBL] [Abstract][Full Text] [Related]